Order Article Reprints

Nunes MA, Toricelli M, Schöwe NM, Malerba HN, Dong-Creste KE, Farah DMAT, De Angelis K, Irigoyen MC, Gobeil F, Araujo Viel T, et al. Kinin B2 Receptor Activation Prevents the Evolution of Alzheimer’s Disease Pathological Characteristics in a Transgenic Mouse Model. Pharmaceuticals. 2020; 13(10):288. https://doi.org/10.3390/ph13100288

Nunes, Marielza Andrade, Mariana Toricelli, Natalia Mendes Schöwe, Helena Nascimento Malerba, Karis Ester Dong-Creste, Daniela Moura Azevedo Tuma Farah, Katia De Angelis, Maria Claudia Irigoyen, Fernand Gobeil, Tânia Araujo Viel, and et al. 2020. "Kinin B2 Receptor Activation Prevents the Evolution of Alzheimer’s Disease Pathological Characteristics in a Transgenic Mouse Model" Pharmaceuticals 13, no. 10: 288. https://doi.org/10.3390/ph13100288

Nunes, M. A., Toricelli, M., Schöwe, N. M., Malerba, H. N., Dong-Creste, K. E., Farah, D. M. A. T., De Angelis, K., Irigoyen, M. C., Gobeil, F., Araujo Viel, T., & Buck, H. S. (2020). Kinin B2 Receptor Activation Prevents the Evolution of Alzheimer’s Disease Pathological Characteristics in a Transgenic Mouse Model. Pharmaceuticals, 13(10), 288. https://doi.org/10.3390/ph13100288